Today, patients are often forced to endure days of waiting for lab results. As a result, doctors may initiate unnecessary isolation or empirical treatment based on incomplete information. This approach is costly and can be harmful to patients.
Our technology will enable doctors to rapidly select optimal treatment for their patients — providing physicians and those they treat with greater peace of mind.
COVID-19 is the first infectious disease that the Talis One System will support. Future infectious disease indications may include assays for other respiratory infections, such as influenza, as well as sexually transmitted infections (STIs) and other infections impacting women’s health.
Faster diagnosis leads to better therapy: Personalized therapies that work from day one help accelerate recovery and minimize side effects.
Faster results, greater confidence: Rapid innovative tests inform better treatment decisions.
Better care experience that reduces cost and improves outcomes: Optimal personalized treatments reduce the length of stay.
Systemic healthcare spend is better managed: Cost-efficient, near-patient testing regardless of the care setting, from physician office to hospital bedside.
Talis is dedicated to providing broad access to fast, highly accurate, actionable diagnostic testing at the point of care to ensure better treatment and disease management for patients with COVID-19 and other infectious diseases.
©2020 Talis Biomedical. All Rights Reserved.
